Danwei Huangfu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danwei Huangfu has a total of 459 co-authors. Here are the top co-authors by number of shared publications:
Renhe Luo
18 shared publicationsDingyu Liu
Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA
14 shared publicationsDapeng Yang
Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
13 shared publicationsJielin Yan
Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
12 shared publicationsQing V. Li
Developmental Biology Program, Sloan Kettering Institute, New York, USA
12 shared publicationsWilfred Wong
Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medical College, New York, NY, USA; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Tri-Institutional Training Program in Computational Biology and Medicine, New York, NY, USA
11 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (11)
NANOG and OCT4 dosage shapes non-monotonic gene expression responses during stem cell differentiation
- 14 November 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (11)
Open AccessNANOG and OCT4 dosage shapes non-monotonic gene expression responses during stem cell differentiation
- Open Access
Perturbation-induced gene programs map the hidden regulatory architecture of complex diseases
Steady-state molecular profiles incompletely capture the regulatory programs through which genetic variation influences complex disease, particularly programs that emerge only when cells are perturbed. Here, we introduce Perturbscape, a computational framework that learns multiscale gene programs for individual perturbations in a CRISPR Perturb-seq screen using linear and nonlinear contrastive approaches alongside complementary program-learning methods, and integrates them with human genetics to prioritize disease-relevant genes, perturbations and downstream regulatory pathways. Across 15,859 perturbation-by-context profiles from 7 Perturb-seq systems and 53 complex diseases and traits (mean GWAS N=291K), perturbation-induced programs showed up to 4.3-fold higher heritability informativeness than analogous steady-state multi-tissue gene prioritization, and retained significant conditional heritability informativeness across all 34 matched cell system–trait comparisons after accounting for steady-state prioritization. Preserving perturbation-specific programs further yielded 2.5–5.3-fold higher trait relevance scores than programs derived from control cells, pooled perturbations or differential-expression summaries. In K562, Perturbscape-prioritized genes showed stronger enrichment for rare-variant burden genes than steady-state prioritization and were supported by orthogonal enhancer CRISPRi screens. In HepG2, LDL cholesterol-associated perturbation– induced programs specifically revealed statin-responsive pathways not significantly enriched by steady-state PoPS prioritization, supported by pharmacological transcriptional responses and population plasma proteomics. Perturbscape also recovered blood-related trait-conditioned trans-regulatory relationships that were specifically supported by population trans-eQTLs in IFN-γ-stimulated monocytes (OR = 1.30, P=1.6e-05). Perturbscape further revealed developmental-stage-specific convergence between monogenic diabetes regulators and polygenic T2D risk during pancreatic islet differentiation, and neuronal-subclass-specific autism-associated regulatory programs in vivo . Together, these findings establish perturbation-induced gene programs as a complementary layer of disease-relevant regulatory information, revealing genetically informative pathways and context-specific regulatory relationships incompletely represented by steady-state molecular atlases.
Open AccessPerturbation-induced gene programs map the hidden regulatory architecture of complex diseases
Steady-state molecular profiles incompletely capture the regulatory programs through which genetic variation influences complex disease, particularly programs that emerge only when cells are perturbed. Here, we introduce Perturbscape, a computational framework that learns multiscale gene programs for individual perturbations in a CRISPR Perturb-seq screen using linear and nonlinear contrastive approaches alongside complementary program-learning methods, and integrates them with human genetics to prioritize disease-relevant genes, perturbations and downstream regulatory pathways. Across 15,859 perturbation-by-context profiles from 7 Perturb-seq systems and 53 complex diseases and traits (mean GWAS N=291K), perturbation-induced programs showed up to 4.3-fold higher heritability informativeness than analogous steady-state multi-tissue gene prioritization, and retained significant conditional heritability informativeness across all 34 matched cell system–trait comparisons after accounting for steady-state prioritization. Preserving perturbation-specific programs further yielded 2.5–5.3-fold higher trait relevance scores than programs derived from control cells, pooled perturbations or differential-expression summaries. In K562, Perturbscape-prioritized genes showed stronger enrichment for rare-variant burden genes than steady-state prioritization and were supported by orthogonal enhancer CRISPRi screens. In HepG2, LDL cholesterol-associated perturbation– induced programs specifically revealed statin-responsive pathways not significantly enriched by steady-state PoPS prioritization, supported by pharmacological transcriptional responses and population plasma proteomics. Perturbscape also recovered blood-related trait-conditioned trans-regulatory relationships that were specifically supported by population trans-eQTLs in IFN-γ-stimulated monocytes (OR = 1.30, P=1.6e-05). Perturbscape further revealed developmental-stage-specific convergence between monogenic diabetes regulators and polygenic T2D risk during pancreatic islet differentiation, and neuronal-subclass-specific autism-associated regulatory programs in vivo . Together, these findings establish perturbation-induced gene programs as a complementary layer of disease-relevant regulatory information, revealing genetically informative pathways and context-specific regulatory relationships incompletely represented by steady-state molecular atlases.
- Open Access
A dish-to-biobank framework links β-cell nutrient-stress programs to genetic and dietary risk for Type 2 Diabetes
Type 2 diabetes (T2D) arises from genetic susceptibility and chronic metabolic stress, but whether these converge on shared molecular programs in human populations remains unclear. Here, we develop a dish-to-biobank framework linking controlled β-cell perturbation to population-scale disease genetics through the circulating plasma proteome, and apply it to T2D. scRNA-seq of human stem cell–derived islets under factorial glucose and palmitate exposure identifies their combination (glucolipotoxicity) as the condition eliciting the strongest SC-β cell transcriptional response, with glucolipotoxicity-upregulated genes uniquely enriched for T2D heritability, monogenic diabetes genes, and rare-variant burden signals. CRISPR knockout of β-cell identity regulators PAX6 and PDX1 aligns with this program, establishing convergence of environmental and genetic perturbations on a shared disease-relevant state. We then used the plasma proteome as an accessible population-scale readout of these experimentally defined β-cell stress programs, scoring 45,956 UK Biobank White British participants. We define heritable stress signatures that associate with refined carbohydrate and saturated fat intake, and undergo trans-tissue genetic regulation, with a subset of variants showing diet-dependent effects. Together, these findings establish glucolipotoxicity as a genetically anchored model of β-cell dysfunction and provide a generalizable framework for linking controlled cellular perturbations to human disease genetics at population scale.
Open AccessA dish-to-biobank framework links β-cell nutrient-stress programs to genetic and dietary risk for Type 2 Diabetes
Type 2 diabetes (T2D) arises from genetic susceptibility and chronic metabolic stress, but whether these converge on shared molecular programs in human populations remains unclear. Here, we develop a dish-to-biobank framework linking controlled β-cell perturbation to population-scale disease genetics through the circulating plasma proteome, and apply it to T2D. scRNA-seq of human stem cell–derived islets under factorial glucose and palmitate exposure identifies their combination (glucolipotoxicity) as the condition eliciting the strongest SC-β cell transcriptional response, with glucolipotoxicity-upregulated genes uniquely enriched for T2D heritability, monogenic diabetes genes, and rare-variant burden signals. CRISPR knockout of β-cell identity regulators PAX6 and PDX1 aligns with this program, establishing convergence of environmental and genetic perturbations on a shared disease-relevant state. We then used the plasma proteome as an accessible population-scale readout of these experimentally defined β-cell stress programs, scoring 45,956 UK Biobank White British participants. We define heritable stress signatures that associate with refined carbohydrate and saturated fat intake, and undergo trans-tissue genetic regulation, with a subset of variants showing diet-dependent effects. Together, these findings establish glucolipotoxicity as a genetically anchored model of β-cell dysfunction and provide a generalizable framework for linking controlled cellular perturbations to human disease genetics at population scale.
- 19 May 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (6) , 1190-1207.e12
Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation
- 19 May 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (6) , 1190-1207.e12
Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation
- Open Access
- 18 March 2026
- Published by Elsevier in Cell Genomics
- Vol. 6 (5) , 101189
Functional chromatin signatures premark future lineage-specific enhancers
- 18 March 2026
- Published by Elsevier in Cell Genomics
- Vol. 6 (5) , 101189
Open AccessFunctional chromatin signatures premark future lineage-specific enhancers
- Open Access
pertTF: context-aware AI modeling for genome-scale and cross-system perturbation prediction
Predicting genetic perturbation responses at a single-cell level is central to building models for cell state and disease. However, existing approaches are limited on predicting phenotypic outcomes beyond expression changes and generalizing predictions across genome-scale perturbations in biologically relevant contexts. Here we introduce pertTF, a transformer-based single-cell genetic perturbation model. pertTF was trained from a unique dataset capturing single cell expressions profiles of 30 full gene knockouts across 14 relevant cell types during human pancreatic development and beta-cell differentiation. pertTF outperforms current methods in predicting expression changes of perturbing unseen genes in unseen cellular contexts. In addition, pertTF infers perturbation-induced shifts in cell identity and population composition, an important phenotypic outcome of perturbation in many physiology and disease settings. Through transfer learning, pertTF operates in physiologically relevant systems, including primary human islets, where large-scale perturbation experiments are challenging. The generalizability of pertTF is further demonstrated by in silico pooled and single-cell CRISPR screens, capturing critical regulators of stem cells and early pancreatic cell development. These results establish pertTF as a framework for integrating large-scale single-cell perturbation data with AI models to predict genetic perturbation effects across cellular systems and disease contexts.
Open AccesspertTF: context-aware AI modeling for genome-scale and cross-system perturbation prediction
Predicting genetic perturbation responses at a single-cell level is central to building models for cell state and disease. However, existing approaches are limited on predicting phenotypic outcomes beyond expression changes and generalizing predictions across genome-scale perturbations in biologically relevant contexts. Here we introduce pertTF, a transformer-based single-cell genetic perturbation model. pertTF was trained from a unique dataset capturing single cell expressions profiles of 30 full gene knockouts across 14 relevant cell types during human pancreatic development and beta-cell differentiation. pertTF outperforms current methods in predicting expression changes of perturbing unseen genes in unseen cellular contexts. In addition, pertTF infers perturbation-induced shifts in cell identity and population composition, an important phenotypic outcome of perturbation in many physiology and disease settings. Through transfer learning, pertTF operates in physiologically relevant systems, including primary human islets, where large-scale perturbation experiments are challenging. The generalizability of pertTF is further demonstrated by in silico pooled and single-cell CRISPR screens, capturing critical regulators of stem cells and early pancreatic cell development. These results establish pertTF as a framework for integrating large-scale single-cell perturbation data with AI models to predict genetic perturbation effects across cellular systems and disease contexts.
- Open Access
A Genetically Engineered Human Organoid Model Reveals Distinct Genetic and Epigenetic Barriers of Lineage Plasticity in Early PDAC Transformation
The lack of accurate, human-based models recapitulating early-stage pancreatic ductal adenocarcinoma (PDAC) has hindered therapeutic development. Using pluripotent stem cell-derived pancreatic progenitor organoids, we established a human PDAC model that faithfully reproduces the genetic, epigenetic, and transcriptomic trajectory of tumor initiation and progression in vitro , validated against clinical datasets and histopathology. We demonstrate that CDKN2A loss, nearly universal in patients but dispensable in mouse models, is essential for neoplastic transformation when combined with KRAS and TP53 mutations, while SMAD4 loss promotes tumor progression. Multi-omics profiling reveals epigenetic repression of pancreatic lineage program during PDAC initiation, alongside oncogenic AP-1-driven chromatin remodeling. Notably, we identify TET1 suppression as a mechanistic link between oncogenic ERK signaling and the hypermethylation and silencing of essential pancreatic transcription factors. This model captures the genetic and epigenetic determinants of human PDAC, reveals antagonism between oncogenic and lineage restriction programs, and supports TET-based lineage restoration as a promising early intervention strategy for high-risk individuals.
Open AccessA Genetically Engineered Human Organoid Model Reveals Distinct Genetic and Epigenetic Barriers of Lineage Plasticity in Early PDAC Transformation
The lack of accurate, human-based models recapitulating early-stage pancreatic ductal adenocarcinoma (PDAC) has hindered therapeutic development. Using pluripotent stem cell-derived pancreatic progenitor organoids, we established a human PDAC model that faithfully reproduces the genetic, epigenetic, and transcriptomic trajectory of tumor initiation and progression in vitro , validated against clinical datasets and histopathology. We demonstrate that CDKN2A loss, nearly universal in patients but dispensable in mouse models, is essential for neoplastic transformation when combined with KRAS and TP53 mutations, while SMAD4 loss promotes tumor progression. Multi-omics profiling reveals epigenetic repression of pancreatic lineage program during PDAC initiation, alongside oncogenic AP-1-driven chromatin remodeling. Notably, we identify TET1 suppression as a mechanistic link between oncogenic ERK signaling and the hypermethylation and silencing of essential pancreatic transcription factors. This model captures the genetic and epigenetic determinants of human PDAC, reveals antagonism between oncogenic and lineage restriction programs, and supports TET-based lineage restoration as a promising early intervention strategy for high-risk individuals.
- Open Access
STAR Suite: Transcriptomics processing in a single binary through AI-assisted development
The STAR aligner plays a key role in complex transcriptomics pipelines consisting of multiple analytical tools. We present STAR Suite, a drop-in replacement for STAR that internalizes entire pipelines for bulk RNA-seq, scRNA-seq, Perturb-seq, 10x Flex, and SLAM-seq. Deployed by the NIH MorPhiC consortium, STAR Suite provides an open-source alternative to proprietary Cell Ranger pipelines, achieving gene-level Pearson correlations of 0.99–1.0 and 3.8- to 5.7-fold faster speeds for Perturb-seq and Flex analysis through improved methodologies. Integrating multi-module workflows into a single executable makes STAR Suite ready-to-use for both human researchers and the AI agents increasingly used in analytical workflows. STAR Suite was developed using AI agents, enabling a single developer to add 97,000 lines of code to the 28,000-line codebase in four months—illustrating a modern paradigm for large-scale integration of complex open-source codebases by individual research groups. Utilities are included to facilitate future community contributions using AI assistants.
Open AccessSTAR Suite: Transcriptomics processing in a single binary through AI-assisted development
The STAR aligner plays a key role in complex transcriptomics pipelines consisting of multiple analytical tools. We present STAR Suite, a drop-in replacement for STAR that internalizes entire pipelines for bulk RNA-seq, scRNA-seq, Perturb-seq, 10x Flex, and SLAM-seq. Deployed by the NIH MorPhiC consortium, STAR Suite provides an open-source alternative to proprietary Cell Ranger pipelines, achieving gene-level Pearson correlations of 0.99–1.0 and 3.8- to 5.7-fold faster speeds for Perturb-seq and Flex analysis through improved methodologies. Integrating multi-module workflows into a single executable makes STAR Suite ready-to-use for both human researchers and the AI agents increasingly used in analytical workflows. STAR Suite was developed using AI agents, enabling a single developer to add 97,000 lines of code to the 28,000-line codebase in four months—illustrating a modern paradigm for large-scale integration of complex open-source codebases by individual research groups. Utilities are included to facilitate future community contributions using AI assistants.
- Open Access
FourC: identifying significant and differential contacts in 1D chromatin conformation data
4C-seq is a cost-effective 3C-based assay that measures the interactions between a single genomic element and all other genomic elements. However, 4C-seq data remains semi-quantitative because it cannot be deduplicated without UMIs. To address this, we developed an open source method, FourC, based on a Bayesian Bernoulli regression model, that overcomes the duplication problem and models spatial patterns with Gaussian processes to identify significantly enriched and differential contacts. We demonstrate the utility of FourC on 4C-seq data that profiles the local chromatin structure at key genes necessary for pancreatic differentiation and under CRISPR perturbation of enhancers.
Open AccessFourC: identifying significant and differential contacts in 1D chromatin conformation data
4C-seq is a cost-effective 3C-based assay that measures the interactions between a single genomic element and all other genomic elements. However, 4C-seq data remains semi-quantitative because it cannot be deduplicated without UMIs. To address this, we developed an open source method, FourC, based on a Bayesian Bernoulli regression model, that overcomes the duplication problem and models spatial patterns with Gaussian processes to identify significantly enriched and differential contacts. We demonstrate the utility of FourC on 4C-seq data that profiles the local chromatin structure at key genes necessary for pancreatic differentiation and under CRISPR perturbation of enhancers.
- Open Access
A stem cell knockout village reveals lineage rewiring and a non-canonical islet cell fate in monogenic diabetes
Genetics studies have identified a core set of regulators essential for pancreatic β cell development, many of which are mutated in monogenic diabetes. However, how these mutations alter developmental trajectories to produce pathological cell states remains elusive. Here we introduce a knockout village framework that enables longitudinal scRNA-seq profiling of 79 human pluripotent stem cell mutant lines targeting 30 developmental regulators, including 15 diabetes genes, across five islet differentiation stages. We show that loss of lineage regulators impairs β cell formation in a stage-specific manner and rewires developmental trajectories towards competing lineages. Notably, several monogenic diabetes gene mutations drive a shift from β cells to enterochromaffin (EC)-like cells, a recently recognized non-canonical islet cell fate. These EC-like cells exhibit incomplete activation of hormone regulation programs, along with elevated neuron signatures. Leveraging the diversity of cell fate outcomes across mutants, we predicted and experimentally validated ISL1 as a key downstream effector of PDX1 and PAX6 that safeguards β cell identity against an EC-like fate. Together, our findings reveal cell fate rewiring as a widespread, previously underappreciated pathological mechanism in monogenic diabetes and establish a scalable platform for uncovering developmental vulnerabilities in human genetic disorders.
Open AccessA stem cell knockout village reveals lineage rewiring and a non-canonical islet cell fate in monogenic diabetes
Genetics studies have identified a core set of regulators essential for pancreatic β cell development, many of which are mutated in monogenic diabetes. However, how these mutations alter developmental trajectories to produce pathological cell states remains elusive. Here we introduce a knockout village framework that enables longitudinal scRNA-seq profiling of 79 human pluripotent stem cell mutant lines targeting 30 developmental regulators, including 15 diabetes genes, across five islet differentiation stages. We show that loss of lineage regulators impairs β cell formation in a stage-specific manner and rewires developmental trajectories towards competing lineages. Notably, several monogenic diabetes gene mutations drive a shift from β cells to enterochromaffin (EC)-like cells, a recently recognized non-canonical islet cell fate. These EC-like cells exhibit incomplete activation of hormone regulation programs, along with elevated neuron signatures. Leveraging the diversity of cell fate outcomes across mutants, we predicted and experimentally validated ISL1 as a key downstream effector of PDX1 and PAX6 that safeguards β cell identity against an EC-like fate. Together, our findings reveal cell fate rewiring as a widespread, previously underappreciated pathological mechanism in monogenic diabetes and establish a scalable platform for uncovering developmental vulnerabilities in human genetic disorders.